lifestyle.wordsjournal.com

Author: ENA Respiratory

ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

May 11, 2026
ENA Respiratory Appoints Melissa Faris to Board

April 23, 2026
ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

January 29, 2026